Prof Simon Rule (Derriford Hospital, Plymouth, UK) chairs a discussion with Prof Vitolo (University-Hosptial, Torino, Italy), Prof Zinzani (University of Bologna, Bologna, Italy), and Prof Zucca (Oncology Institute of Southern Switzerland, Bellinzona, Switzerland) for ecancertv, about the treatment of mantle cell lymphoma (MCL).

They discuss the main classes of treatment in current use for MCL, including chemotherapy, immune based therapy and radioimmuotherapy, the role of new biologic agents in the treatment of patients with MCL, treatment options for older patients, and new treatments and approaches currently being investigated, with particular reference to new data.

This programme has been supported by an unrestricted educational grant from Janssen Pharmaceutica (A Johnson & Johnson Company).